Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05548335
Other study ID # 21036
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 31, 2024

Study information

Verified date August 2023
Source Cleveland Clinic Akron General
Contact Joshua Jacquet, MD
Phone 330-344-6000
Email jacquej3@ccf.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a prospective assessment of the accuracy of ocular ultrasound as a tool to measure the diameter of the optic nerve sheath and the eyeball transverse diameter in healthy adult patients presenting to the Emergency Department and have confirmatory imaging of the optic nerve as part of their clinical care.


Description:

This will be a prospective evaluation of accuracy of microconvex and linear transducers for ultrasound measurements of the ONSD and the ETD. Study population will be adult patients that present to Cleveland Clinic Akron General Emergency Department between July 1, 2022 and July 31 April 1, 2023. Patients will be identified on the Emergency Medicine Department tracking board. Patients, once identified as meeting inclusion criteria will be asked to participate in this study and full written consent will be required. All participants will have identical procedures and there will be no groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date December 31, 2024
Est. primary completion date December 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - 18 years of age and older, and; - Present to Cleveland Clinic Akron General's ED (Main) - Have CT head and/or ocular ordered as a part of clinical care that is read as normal or no acute disease (confirmatory imaging), and; - Agree to and provide written consent for participation. Exclusion criteria: - Acute ocular pathology - Abnormal brain and/or ocular CT - History of increased intracranial pressure or optic nerve disease - Not medically stable - Pregnant or incarcerated - Unable to consent.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ocular Ultrasound
1. Patients presenting to the emergency department and have a normal head and/or ocular computed tomography scan will be considered for inclusion in this study. Study staff will discuss the study with the patient and obtain consent. At that point, operator will perform ocular ultrasound. Procedure will start with either the linear or microconvex probe. A single-use sterile gel packet will be used to apply gel to one closed eyelid. The probe will be placed with minimal pressure on the eye. A transverse measurement of the ONSD will be taken. In this same view the maximal transverse diameter of the eyeball will also be measured. Images of the eye with ONSD and ETD measurements will be captured. Repeat until three measurements have been obtained resulting in an average ONSD and ETD for that eye. Repeat for other eye. Switch probe and repeat on both eyes.

Locations

Country Name City State
United States Cleveland Clinic Akron General Akron Ohio

Sponsors (1)

Lead Sponsor Collaborator
Cleveland Clinic Akron General

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Primary objective is to determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the optic nerve sheath diameter compared to CT measurements. The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done. through study duration, one year is anticipated.
Secondary To determine the level of intra- and inter-rater variability for ultrasound measurement of the optic nerve sheath diameter between the two transducer types. The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done. through study duration, one year is anticipated.
Secondary To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the eyeball transverse diameter compared to CT measurements. The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done. through study duration, one year is anticipated.
Secondary To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the ONSD/ETD compared to CT measurements. The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done. through study duration, one year is anticipated.
See also
  Status Clinical Trial Phase
Completed NCT00772525 - Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis Phase 2
Recruiting NCT04316208 - Effect of PEEP on Subdural Pressure, Optic Nerve Sheath Diameter, Lung Compliance and Brain Perfusion Pressure N/A
Active, not recruiting NCT06168578 - The Effect of Alveolar Recruitment Manoeuvre on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomies
Completed NCT06077929 - Optic Nerve Course Variants in Nepali Population
Completed NCT00404729 - Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases Phase 4